< Back to situation

[REVISION HISTORY]

Brazil blood donation regulation updates

Updated 9 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-19 14:10 UTC → 2026-08-24 18:20 UTC · added removed

The Brazilian Ministry of Health is implementing Ordinance GM/MS nº 11.685/2026 to modernize blood donation regulations based on current scientific and epidemiological evidence. While the Santa Catarina Hematology and Hemotherapy Center (Hemosc) and the Amapá Institute of Hematology and Hemotherapy (Hemoap) have already begun implementing these standards, the regulations, with a nationwide transition is scheduled to take effect by September 30 or during for October 2026. Significant The updates aim to expand the donor pool and increase hospital supplies by adjusting eligibility criteria and reducing waiting periods. Significant changes include the removal of removing the maximum age limit for healthy regular donors over 70, provided they were already active donors before reaching the age limit and pass clinical evaluations. This change acknowledges that chronological age alone does not determine donation capability. 70. Waiting periods for various procedures have been reduced. Tattoos, reduced: tattoos, piercings, or permanent makeup, and aesthetic procedures like Botox and or fillers now require only a seven-day wait if performed in licensed facilities with valid sanitary permits, compared to longer waits for unlicensed establishments. If safety compliance cannot be verified, permits; otherwise, the waiting period for such procedures extends to wait is four months. Piercings in the mouth or genital area require a four-month wait following removal. Other reductions include bariatric surgery (from 12 to (to six months), tuberculosis (from five (to two years to two), post-cure), and endoscopy or colonoscopy (from six to (to four months). Additionally, the waiting period The wait after sexual contact with casual or unknown partners will decrease from 12 to four months. Cancer survivors Additionally, users of medications such as Ozempic, Wegovy, or Mounjaro may donate five years after treatment. Certain thyroid conditions, such as Hashimoto’s thyroiditis and hyperthyroidism (excluding Graves’ disease), are also no longer permanent disqualifiers. a 14-day waiting period following a dose change or the cessation of adverse effects. To enhance safety, the regulations mandate the use of the ISBT 128 international standard and the NAT Plus malaria test developed by Bio-Manguinhos/Fiocruz, which allows allowing individuals exposed to malaria-endemic areas to donate after 30 days instead of one year. days. Cancer survivors (excluding melanoma and hematological neoplasms) may donate five years after treatment. Furthermore, the new regulations extend the shelf life of platelet concentrates will be extended from five to seven days.

Versions

  1. 2026-08-24 18:20 UTC Brazil blood donation regulation updates
  2. 2026-08-19 14:10 UTC Brazil blood donation regulation updates
  3. 2026-08-17 18:22 UTC Brazil blood donation regulation updates
  4. 2026-08-15 22:10 UTC Brazil blood donation regulation updates
  5. 2026-08-14 14:33 UTC Brazil blood donation regulation updates
  6. 2026-08-13 15:01 UTC Brazil blood donation regulation updates
  7. 2026-08-13 10:48 UTC Brazil blood donation regulation updates
  8. 2026-08-12 23:41 UTC Brazil blood donation regulation updates
  9. 2026-08-12 22:33 UTC Brazil blood donation regulation updates
  10. 2026-08-10 14:34 UTC Brazil blood donation regulation updates

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.